A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19

NCT04780685 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19

Interventions

BIOLOGICAL: hMSC

Sponsor

Stemedica Cell Technologies, Inc.

Collaborators

[object Object]